Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5.
Takeuchi K, Kohn TJ, Honigschmidt NA, Rocco VP, Spinazze PG, Hemrick-Luecke SK, Thompson LK, Evans DC, Rasmussen K, Koger D, Lodge D, Martin LJ, Shaw J, Threlkeld PG, Wong DT.
Takeuchi K, et al.
Bioorg Med Chem Lett. 2006 May 1;16(9):2347-51. doi: 10.1016/j.bmcl.2005.11.007. Epub 2005 Nov 17.
Bioorg Med Chem Lett. 2006.
PMID: 16298130